IL23受体基因多态性可预测抗TNF-α诱导的炎症性肠病矛盾性银屑病
本研究为回顾性队列研究,纳入499例接受抗TNF-α治疗的成人IBD患者,评估IL23R1142G>A单核苷酸变异与矛盾性银屑病(PP)发生的关联。结果显示PP发生率为5.1%(29/570次暴露),IL23R变异基因型与PP发生高度相关(46.2% vs. 5.1%,OR=17.8,95%CI 7.8-40.0,p<0.0001),未发现其他临床变量与PP相关。
要点
- IL23R1142G>A变异基因型与抗TNF-α诱导的PP高度相关(OR=17.8)。
- PP发生率为5.1%,多数患者需停用抗TNF-α治疗。
- IL23R基因变异可能作为预测PP风险的临床工具。
核心结论
- IL23R基因变异可能识别抗TNF-α诱导PP的风险个体,超越临床变量。
研究设计与样本
- 回顾性队列研究,纳入499例接受抗TNF-α治疗的成人IBD患者,共570次暴露。
主要发现
- PP发生率为5.1%(29/570次暴露),多数患者为重度PP(69.0%)且需停药(69.0%)。
- IL23R1142G>A变异基因型与PP发生高度相关(46.2% vs. 5.1%,OR=17.8,95%CI 7.8-40.0,p<0.0001)。
- 未发现其他临床变量与PP发生相关。
临床怎么用
- IL23R基因变异检测可能有助于识别抗TNF-α治疗中PP高风险患者,指导安全用药。
局限性
- 需进一步验证以推广其作为临床可操作工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Paradoxical psoriasis (PP) is an adverse drug reaction associated with anti-tumour necrosis factor (TNF)-α therapy leading to disfiguring skin lesions that may impact an individual's quality of life and affect their inflammatory bowel disease (IBD) care. To date, there are no tools to identify individuals at risk for PP. IL-23 receptor (IL23R) gene polymorphisms have been linked to psoriasis and may be implicated in PP. AIMS: To evaluate the association between the IL23R1142G>A single nucleotide variant and the occurrence of PP in an anti-TNFα-treated IBD population and assess other clinical variables associated with PP development. METHODS: In a retrospective cohort study conducted in anti-TNFα-exposed adult patients with IBD, participants were screened for the IL23R1142G>A variant genotype and the occurrence of PP was assessed. Participants were additionally assessed for clinical variables associated with PP development and for the impact of PP on IBD treatment. RESULTS: Among 499 patients, the incidence of PP was 5.1% (29/570) with 570 unique anti-TNFα exposures. Most patients had severe PP (69.0%) and required treatment cessation (69.0%), which resulted in complete resolution of PP. An IL23R1142G>A variant genotype was highly associated with PP development (46.2% vs. 5.1%, OR = 17.8, 95% CI 7.8-40.0; p < 0.0001). No other clinical variables were associated with the occurrence of PP. CONCLUSIONS: Variation in the IL23R gene may identify those at risk of anti-TNFα-induced PP, beyond clinical variables. Further validation of this finding may promote its utility as a clinically actionable tool for the safe delivery of IBD medical therapy.
引用
- Natt N, Gindi M, Dela Cruz GR, et al. IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease. Aliment Pharmacol Ther. 2025. PMID: 40958496. doi:10.1111/apt.70377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。